Madrigal Pharmaceuticals, Inc. (MDGL)
552.47
-1.45
(-0.26%)
USD |
NASDAQ |
Dec 10, 16:00
545.69
-6.78
(-1.23%)
After-Hours: 20:00
Madrigal Pharmaceuticals Profit Margin (Quarterly): -39.75% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Amicus Therapeutics, Inc. | 10.24% |
| Insmed, Inc. | -260.0% |
| Ionis Pharmaceuticals, Inc. | -82.06% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.56% |
| Return on Assets | -26.33% |
| Return on Invested Capital | -32.91% |
| Gross Profit Margin (Quarterly) | 93.57% |
| Operating Margin (Quarterly) | -39.68% |
| Return on Net Operating Assets | -231.5% |